Kalkine has a fully transformed New Avatar.

small-cap

One stock that surged up and one that slipped on ASX - a2 Milk and Investa Office Fund

Oct 04, 2017 | Team Kalkine
One stock that surged up and one that slipped on ASX - a2 Milk and Investa Office Fund

a2 Milk Company Ltd


A2M Details

Trading at higher levels: a2 Milk Company Ltd (Australia) (ASX: A2M) rallied over 4.9% on October 04, 2017 leading to a total rally of over 23% in the last four weeks. On one hand, a research note from Goldman Sachs entails a buy rating on the stock with a $7.25 price target at the back of growth from developments in China; and on the other hand, the market saw Deutsche Bank downgrading the rating to hold for A2M shares.

Lately, A2M reported that Synlait (ASX: SM1) has received registration by CFDA (China Food and Drug Administration), which would enable exports of the group’s China label infant formula to China to continue. This registration is a significant one for A2M, who had acquired an additional 8.2% shareholding in Synlait in March 2017 given the growing success of their infant formula in Asia Pacific region. On the other hand, A2M already generated over 197.5% in this year to date (as of October 03, 2017) placing them at a very high price to earnings ratio. We think that the stock is overvalued at the current price of $ 6.31

Investa Office Fund


IOF Details

Attractive return on equity: Investa Office Fund (ASX: IOF) has recently reported that Investa Property Group acquired 59.3 million securities in IOF, reflecting 9.89% of IOF’s issued securities, from Cromwell Property Group for $276 million. This move has enhanced Investa Property Group’s co-investment stake in IOF to 19.95%. IOF has been seen to outperform the S&P/ASX200 A-REIT Index and their peers in FY17. Further, IOF is known to have total assets under management of $3.8 billion, with 20 investment grade office buildings in core CBD markets across Australia. With rise in earnings, distributions, and portfolio value, the fund has delivered an attractive return on equity over FY17. The stock has a decent dividend yield and has fallen about 4.8% this year to date (as at October 03, 2017). IOF is trading at reasonable levels from an investment point of view andwe give a “Buy” at the current price of $ 4.38


Five-year performance (Source: Company Reports)


Disclaimer
 
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.